STEOVESS alendronic acid (as sodium) 70mg effervescent tablet blister pack

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

alendronate sodium, Quantity: 91.37 mg (Equivalent: alendronic acid, Qty 70 mg)

Disponibbli minn:

Pharmbio Pty Ltd

INN (Isem Internazzjonali):

alendronate sodium

Għamla farmaċewtika:

Tablet, effervescent

Kompożizzjoni:

Excipient Ingredients: monosodium dihydrogen citrate; citric acid; sodium bicarbonate; sodium carbonate; acesulfame potassium; sucralose; Flavour

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

4, 1, 2

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

Steovess is indicated for the treatment of osteoporosis. Prior to treatment, osteoporosis must be confirmed by the finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by the presence of osteoporotic fracture

Sommarju tal-prodott:

Visual Identification: White to off-white round, flat tablet with bevelled edges; Container Type: Blister Pack; Container Material: Other composite material; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2012-06-18